Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
Regular Articles
Current Status and Issues of Mental Health among Hospital Pharmacists during the Long-term Novel Coronavirus Disease 2019 (COVID-19) Pandemic:
Report on a Questionnaire Survey in 32 Rosai Hospitals
Takatoshi ShiraishiTakuya SakamotoHitomi KawamuraShunnosuke KinjoKazutaka OkudaKota KomatsuAsuka OzawaYuji KonishiHiroto Arai
Author information
JOURNAL FREE ACCESS

2022 Volume 48 Issue 2 Pages 70-78

Details
Abstract

We conducted a questionnaire survey to elucidate the current status and issues of mental health facing hospital pharmacists during the long-term COVID-19 pandemic, and to obtain information for providing mental health support. The questionnaire collection rate was 87.8%. The study finally involved 448 hospital pharmacists in 32 Rosai hospitals. The results revealed that 61.8% of hospital pharmacists reported feeling stress. From the logistic regression analysis, it was clarified that “prejudice or discrimination against healthcare workers” was significantly associated with work stress and high levels of anxiety. It was considered that feeling stress and anxiety about “prejudice or discrimination against healthcare workers” is a common problem among all health care workers, and it requires immediate solution. In this study, psychiatric symptoms were observed in 216 hospital pharmacists (48.8%). In addition, the onset of psychiatric symptoms was significantly higher among hospital pharmacists who reported feeling high levels of work stress and anxiety. These findings suggest that psychiatric symptoms among hospital pharmacists due to high levels of work stress and anxiety is of great concern as it may lead to mental health disorders. The factors that influence mental health are interrelated, and it is necessary to enhance organizational mental health support. We hope that these findings will be useful for preventing mental health disorders during the long-term COVID-19 pandemic.

Content from these authors
© 2022 Japanese Society of Pharmaceutical Health Care and Sciences
Previous article Next article
feedback
Top